Russia's "2020 Pharma Strategy" Spurs $2.25 Billion Manufacturing Investment Spike, an Industrial Info Market Brief
Industrial Info's Pharmaceutical-Biotech team is reporting an uptick in drug-manufacturing capital investment in Russia. This is a direct result of the Russian government's "Pharma 2020 Strategy."
